Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Cisplatin alone or in combination versus hydroxyurea during pelvic irradiation for cervical cancer

Nature Clinical Practice Oncology volume 5, pages 128–129 (2008)Cite this article

boxed-textRose PG et al. (2007) Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: a Gynecologic Oncology Group study. J Clin Oncol 19: 2804–2810

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Eifel PJ et al. (2004) Pelvic irradiation therapy with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer. J Clin Oncol 22: 872–880

    Article  Google Scholar 

  2. Morris M et al. (1999) Pelvic radiation with concurrent chemotherapy versus pelvic and para-aortic radiation for high risk cervical cancer: a randomized Radiation Therapy Oncology Group clinical trial. N Engl J Med 340: 1137–1143

    Article  CAS  Google Scholar 

  3. Rose PG et al. (2007) Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: a Gynecologic Oncology Group study. J Clin Oncol 25: 2804–2810

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Mandy Aujla, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. and Vice Chair of the Department of Radiation Oncology, D Rades is Associate Professor of Radiation Oncology, at the University Hospital Schleswig-Holstein, Luebeck, Germany,

    Dirk Rades

  2. and Vice Chair of the Department of Radiation Oncology, SE Schild is Professor of Radiation Oncology, at the Mayo Clinic, Scottsdale, Arizona, USA.,

    Steven E Schild

Authors
  1. Dirk Rades
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Steven E Schild
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dirk Rades.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rades, D., Schild, S. Cisplatin alone or in combination versus hydroxyurea during pelvic irradiation for cervical cancer. Nat Rev Clin Oncol 5, 128–129 (2008). https://doi.org/10.1038/ncponc1017

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncponc1017

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing